PPCP Review Spring Midterm

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/75

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

76 Terms

1
New cards

doing an assessment and prioritizing

What is the key to assessing a patient?

2
New cards

1) identify all the health conditions

2) assess those conditions identified

3) prioritize based on assessment

what are the 3 steps you should take when assessing and prioritizing health conditions?

3
New cards

use of a variety of sources like PMH and new conditions are based on symptoms the patient is complaining about which led to the visit

How do you identify health conditions?

4
New cards

How to do a correct assessment of conditions identified

-list level, stage, classification if applicable

-controlled, asymptomatic, or stable

-> if NOT then why

5
New cards

Indication, Effectiveness, Safety, Adherance

What are the medication related needs?

6
New cards

Indication

-Unnecessary med therapy

-Needs additional med therapy

7
New cards

Effectiveness

-ineffective med

-dosage too low

-needs additional monitoring

8
New cards

Safety

-adverse med event

-dosage too high

-needs additional monitoring

9
New cards

Adherance

-Adherence

-Cost

10
New cards

the middle (Med Therapy Problem Category)

When looking at the MTP chart to classify our problems what section should we look at first?

11
New cards

Unnecessary med therapy

•Medication has no indication

•Duplicate medication or class

12
New cards

Dosing, Administration, or storage issue

•Dose too high or too low

•Incorrect or inappropriate dosing regimen, formulation, route, frequency, duration, titration/taper, etc.

•Incorrect storage

13
New cards

Adverse event or monitoring

•Medication-related or allergy-related adverse effect

•Lack of appropriate monitoring

14
New cards

Drug interactions

•Drug-drug , drug-disease, or drug-food interactions

15
New cards

Compliance or cost issues

•Adherence or administration issues

•Cost concerns

Patient lack of understanding

16
New cards

no think about what matters in this situation

Should you always list every interaction when assessing a patient?

17
New cards

-most pressing/serious issue

-what they are there to treat

What do we usually prioritize problems based on?

18
New cards

plan

Where is rationale found in the PPCP wheel?

19
New cards

Rationale for Recommendations

•What are you basing your recommendations on (DI references, clinical guidelines, primary literature)?

•What information from primary literature and guidelines supports this recommendation?

•Why are you recommending this over other potential therapy options (why this class, why this agent within the class)?

•Are there any patient-specific factors for choosing this?

20
New cards

problem solvimg

depends on critical thinking skills

21
New cards

clinical reasoning

depends on evidence-based knowledge

22
New cards

clinical decision making

depends on argument construction

23
New cards

supports

Rationale ___________ your clinical-decision making.

24
New cards

1) Optimize Care Plan (Therapeutic Monitoring)

2) Identify and resolve med therapy problems (Adverse event monitoring)

What are the goals of Follow up?

25
New cards

therapeutic monitoring

-Relate back to your goals of therapy

-May vary from disease state to disease state

-Often found in disease state guidelines

-Commonly related to lab value or diagnostic test (i.e. blood pressure) BUT can also be the absence of an event (i.e.- prevention of heart attack or stroke)

-Should include what you will measure, HOW you will measure, AND when you will measure it

26
New cards

Monitoring Parameter

This will be the specific item that is evaluated to determine if the intervention is effective

27
New cards

How to Monitor

-How is this item going to be evaluated?

-Ex: drawing a lab, PE, asking about symptoms

28
New cards

When to Monitor

This is timeline for when you will perform the monitoring task

29
New cards

Plan

Should include what your plan would be if the monitoring parameter is not met

30
New cards

FALSE

When adverse event monitoring you should just list side effects. T or F

31
New cards

Implement

•Addressing medication-related problems

•Engaging in preventive care strategies

•Initiating, modifying, discontinuing, or administering therapy

•Providing education and self-management training

•Contributing to coordination of care, including the referral or transition of the patient to another health care professional

•Scheduling follow-up care as needed to achieve goals of therapy

32
New cards

collaboration

The practitioner implements the care plan in ___________ with other health care professionals and the patient or caregiver.

33
New cards

preventative services

help you stay healthy, detect health problems early, determine the most effective treatments, and prevent certain diseases

EX: vaccines, health screenings, educaiton

34
New cards

Part B

What part of Medicare covers preventative services?

35
New cards

Common Health Screenings

-Point of care testing

-health risk assessment

-depression screening

-anxiety screening

-cognitive screening

-fall prevention

-cancer screenings

36
New cards

medicare wellness visit

Preventative health appointments for Medicare beneficiaries with a goal to prevent disease or disability

37
New cards

no they cannot because they are not seen as providers by Medicare part b

Pharmacist can complete annual wellness visits, however, they cannot directly bill for this service?

38
New cards

immunization considerations

-practice site

-qualifications

-protocols

-administration

39
New cards

travel vaccines

-HEP A

-HEP B

-Meningococcal

-Measles

-Rabies

-Typhoid (live or inactivated)

-Yellow fever

-Japanese encephalitis

40
New cards

VAERS

national vaccine safety surveillance program that helps to detect unusual or unexpected reporting patterns of adverse events for vaccines

41
New cards

anyone

VAERS accepts reports from ____________ including patients, family members, healthcare providers and vaccine manufacturers. (reports of vaccination errors)

42
New cards

required by law

Healthcare providers are ____________ to report to VAERS.

43
New cards

Mississippi Immunization Information eXchange (MIIX)

-Mississippi State Department of Health State Immunization Registry

-allows you to search and view patient's vaccination record

44
New cards

-CDC

-Pneumorecs

-Prevention Taskforce

What are the recommended apps about vaccines?

45
New cards

pharmacist implementation

-addresses medication

-initiates, modifies, discontinues, or administers medication therapy as authorized

-provides education and self management training to the patient or caregiver

-contributes to coordination of care, including the referral or transition of the patient to another health care professional

-schedules follow up care prn to achieve goals of therapy

46
New cards

scope of practice

the boundaries within which a health professional may practice

-largely determined by statutes enacted by state legislatures and by rules adopted by the appropriate licensing entity

47
New cards

state boards of pharmacy

For pharmacists, scope of practice is regulated by what?

48
New cards

initiation authorized under CPA in MS

-Hormonal contraception

-Tobacco cessation aids

-"Test and Treat"

-Naloxone

-Glucagon

49
New cards

modify authorized under CPA in MS

•Quantity (30-to-90-day switch)

•Therapeutic substitution

•Dose adjustments based on lab monitoring

50
New cards

Discontinue authorized under CPA in MS

•Antibiotic Stewardship

•Medication Therapy Management

•BEERS Criteria for Geriatric Patients

51
New cards

Administer authorized under CPA in MS

•Vaccinations

•Long-acting Injectables

•Antipsychotics

•Contraception

•Vitamins

•Hormones

52
New cards

continuum of pharmacist prescriptive authority

This authority exists somewhere along a continuum and is either dependent (delegated through a collaborative practice agreement) or independent (authority comes directly from the state, no delegation required) authority

53
New cards

-collaborative prescribing

-autonomous prescribing

-credentialing/privileging

What are the mechanisms to expand pharmacist's scope of practice?

54
New cards

Collaborative Practice Agreements (CPAs)

-create formal practice relationships between pharmacists and prescribers

-Serve to improve the efficiency and effectiveness of collaborative care delivery

55
New cards

-increase access to care

-expand available services

-increase the efficiency and coordination of care

-leverage pharmacists' medication expertise

What are some of the benefits of collaborative practice agreements (CPAs)?

56
New cards

-order laboratory test

-refill authorizations

-management of specific health conditions

What are some examples of services that fall under scope of practice collaborative practice agreements?

57
New cards

nationwide/statewide protocols

are issued by a state board or agency that authorizes pharmacists to prescribe a medication or category of medications under a protocol

58
New cards

statewide standing orders

is an authorization issued by a single prescriber allowing all pharmacists in a state to dispense medication(s) directly to a patient in certain scenarios ​

59
New cards

category-specific prescribing

is when a state authorizes pharmacists to prescribe certain categories of medications without the need for a statewide protocol based on clinical guidelines and professional judgement

60
New cards

credentialing

•a process performed by organizations (e.g., employers, payers, networks) to assess and confirm the qualifications of health care providers

-Ex: board certification, residency certificates

61
New cards

privileging

•grants permission to a pharmacist (or other health care professional) to provide specific services within an organization.

-Ex: Order lab values, pharmacokinetic dosing

62
New cards

-Institution type

-Existing health care culture

-IT infrastructure

-Provider group integration

-State-specific legislation

What is credentialing and privileging limited by?

63
New cards

MTM

-Defined by APhA as a distinct service or group of services that optimize therapeutic outcomes

-Involves identifying, resolving, and preventing medication-related problems

64
New cards

Medication Therapy Review (MTR)

a review of prescription, over-the-counter medications, herbal therapies and dietary supplements

65
New cards

Medication-Related Action Plan (MAP)

A list of action steps for the patient based on identified medication issues ​

66
New cards

Personal Medication Record (PMR)

List of all the patient's medications upon completion

67
New cards

Intervention and/or referral

•Medication-related problem? Contract prescriber

•Expertise of another professional needed? Make referral

68
New cards

Documentation and Follow-up

Documentation, billing

69
New cards

-Medication Therapy Review (MTR)

-Medication-Related Action Plan (MAP)

-Personal Medication Record (PMR)

-Intervention and/or Referral

-Documentation and Follow up

What are the MTM 5 core elements?

70
New cards

monitor the quality of Medicare Part D plans

What is the purpose of Medicare and Medicaid (CMS) star ratings?

71
New cards

value-based care

is evidence-based, outcome driven, and resource appropriate

72
New cards

•Help patients make the best use of their medications

•Earn revenue for professional services

•Demonstrate value to healthcare payers

Quality measure systems present a significant opportunity for pharmacists to do what?

73
New cards

Medication Reconciliation

Reconcile discrepancies and address any issues

74
New cards

Patient Education

Educate patients on proper medication use and adherence

75
New cards

Care Coordination

Communication with other providers to ensure continuity of care

76
New cards

Follow Up

Can reduce serious adverse drug events, use of emergency care, and hospital readmissions